Inventor · disambiguated record
Eugene L. Stewart
Also filed as: STEWART EUGENE L · STEWART EUGENE LEE
12 granted patents·12 pending applications·59 citations·filing 2001–2021
88Inventor score
Files withSMITHKLINE BEECHAM CORP5GLAXOSMITHKLINE IP DEV LTD4GLAXOSMITHKLINE LLC3VIIV HEALTHCARE CO2APOLITO CHRISTOPHER J1
Top patents by PatentIndex Score
24 records- 0192US11697665B2C-mannoside compounds useful for the treatment of urinary tract infectionsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Granted Jul 11, 2023·3 cites·20 claims
- 0291US7834063B2Benzonitryl and nitrobenzyl derivatives that modulate androgen receptorsGLAXOSMITHKLINE LLC·Filed 2005·Granted Nov 16, 2010·28 cites·17 claims
- 0387US7572820B2Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2007·Granted Aug 11, 2009·11 cites·5 claims
- 0483US11111262B2C-mannoside compounds useful for the treatment of urinary tract infectionsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Sep 7, 2021·1 cites·4 claims
- 0583US8026262B2Chemical compoundsGLAXOSMITHKLINE LLC·Filed 2009·Granted Sep 27, 2011·7 cites·20 claims
- 0680US7514470B2Aniline derivatives as selective androgen receptor modulatorsSMITHKLINE BEECHAM CORP·Filed 2005·Granted Apr 7, 2009·4 cites·7 claims
- 0768US7495004B2Purine derivatives as liver X receptor agonistsGLAXO GROUP LTD·Filed 2003·Granted Feb 24, 2009·5 cites·19 claims
- 0862US7723385B2Aniline derivatives as selective androgen receptor modulatorsGLAXOSMITHKLINE LLC·Filed 2009·Granted May 25, 2010·0 cites·5 claims
- 0954US11053234B21,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jul 6, 2021·0 cites·12 claims
- 1052US2005282908A1Substituted aminopropoxyaryl derivatives useful as agonists for LXRSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 1151US12297223B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted May 13, 2025·0 cites·20 claims
- 1246US8673948B2Chemical compoundsTURNBULL PHILIP STEWART·Filed 2011·Granted Mar 18, 2014·0 cites·15 claims
- 1345US2006142387A1Chemical compoundsCADILLA RODOLFO·Filed 2004·Application pending·0 cites
- 1444US2020246351A1Combinations and uses and treatments thereofVIIV HEALTHCARE CO·Filed 2018·Application pending·0 cites
- 1544US2020171039A1Combinations and uses and treatmentsVIIV HEALTHCARE CO·Filed 2018·Application pending·0 cites
- 1643US2006148893A1Chemical compoundsBLANC JEAN-BAPTISTE E·Filed 2004·Application pending·0 cites
- 1743US2009093464A1Naphthalene Derivatives as Modulators of the Glucocorticoid ReceptorSMITHKLINE BEECHMA CORP·Filed 2006·Application pending·0 cites
- 1842US2008221176A1Chemical CompoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 1942US2009170907A1Chemical CompoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 2041US2004072868A1Substitued aminopropoxyaryl derivatives useful as agonists for lxrFiled 2001·Application pending·0 cites
- 2140US2007020684A1Structure of a glucocorticoid receptor ligand binding domain comprising an expanded binding pocket and methods employing sameBLEDSOE RANDY K·Filed 2003·Application pending·0 cites
- 2238US10294214B2Positive allosteric modulators of human melanocortin-4 receptorUNIV VANDERBILT·Filed 2017·Granted May 21, 2019·0 cites·3 claims
- 2334US2007219348A1Mutations in the mineralocorticoid receptor ligand binding domain polypeptide that permit structural determination of low affinity ligand complexes and screening methods employing sameAPOLITO CHRISTOPHER J·Filed 2006·Application pending·0 cites
- 2432US2008227864A1Lhr1 Activators as MedicamentsGOODWIN BRYAN JAMES·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eugene L. Stewart files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →